Estrella Immunopharma Ownership | Who Owns Estrella Immunopharma?
Estrella Immunopharma Ownership Summary
Estrella Immunopharma is owned by 12.30% institutional investors, 61.13% insiders, and 26.57% retail investors. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 0.63% of its assets in Estrella Immunopharma shares.
ESLA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Estrella Immunopharma | 12.30% | 61.13% | 26.57% |
| Sector | Healthcare Stocks | 35.75% | 11.89% | 52.37% |
| Industry | Biotech Stocks | 36.05% | 11.82% | 52.13% |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 16 | 6.67% | 5,178,824 | 418.09% | 12 | 177.41% | 11 | -21.43% | 2 | 100.00% |
| Dec 31, 2025 | 15 | 15.38% | 999,605 | 34.50% | 2 | 65.59% | 14 | 250.00% | 1 | -83.33% |
| Sep 30, 2025 | 13 | 18.18% | 743,186 | 17.07% | 2 | 65.02% | 4 | -33.33% | 6 | 200.00% |
| Jun 30, 2025 | 11 | - | 634,819 | 3.53% | 1 | 61.15% | 6 | 20.00% | 2 | -33.33% |
| Mar 31, 2025 | 11 | - | 613,145 | 109.78% | 1 | 266.87% | 5 | - | 3 | 50.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 268.00K | 0.63% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 148.25K | 0.35% | 33.78K |
| Fidelity Extended Market Index | 105.11K | 0.24% | -384.00 |
| iShares Micro-Cap ETF | 44.11K | 0.10% | - |
| Fidelity Series Total Market Index | 27.55K | 0.06% | 10.75K |
| Northern Trust Extended Eq Market Idx | 19.24K | 0.05% | 10.05K |
| NT Ext Equity Mkt Index Fund - Lending | 19.24K | 0.05% | - |
| Fidelity Total Market Index | 16.76K | 0.04% | - |
| Spartan Extended Market Index Pool F | 9.22K | 0.02% | 384.00 |
| Spartan Total Market Index Pool G | 8.01K | 0.02% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Oct 07, 2025 | Xu Jiandong | Chief Financial Officer | Buy | $1.33K |
| Sep 11, 2025 | Xu Jiandong | Chief Financial Officer | Buy | $104.00 |
| Sep 22, 2025 | Xu Jiandong | Chief Financial Officer | Buy | $1.16K |
| Mar 04, 2022 | Li Jianwei | Co-Chief Executive Officer | Buy | $44.68B |
ESLA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools